Enliven Therapeutics, Inc.

ELVN · Healthcare

$57.86

Markedsværdi: 4.24B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Enliven Therapeutics, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

PR Newswire3. sep. 2026, 20.05

Enliven Therapeutics to Present at Upcoming Investor Conferences

Investor's Business Daily2. sep. 2026, 20.00

Miners And More Lead Slew Of Stocks To Watch — With This Line In Focus

PR Newswire31. aug. 2026, 22.05

Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting

MT Newswires18. aug. 2026, 11.01

William Blair Initiates Enliven Therapeutics at Outperform

MT Newswires18. aug. 2026, 10.58

Mizuho Raises Price Target on Enliven Therapeutics to $73 From $62, Keeps Outperform Rating